Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcriptional regulator HilA is the master control protein for the virulence of Salmonella species, primarily responsible for activating the expression of genes located on Salmonella pathogenicity island 1 (SPI-1). It belongs to the OmpR/ToxR family of transcriptional activators and coordinates the production of the Type III Secretion System (T3SS), a needle-like apparatus essential for the invasion of non-phagocytic host epithelial cells. By sensing environmental cues like osmolarity and oxygen levels, HilA ensures that virulence genes are expressed only when the bacteria reach the appropriate host environment. HilA is a significant therapeutic target in the development of anti-virulence drugs, which aim to prevent infection without killing the bacteria, thereby reducing the selective pressure for antibiotic resistance. Several small molecules and natural compounds, such as quercetin, baicalin, and tannic acid, have been shown to downregulate hilA expression or interfere with its regulatory network, effectively attenuating the pathogen's ability to cause disease.
Inhibition of the transcriptional activation of the Salmonella pathogenicity island 1 (SPI-1) genes, thereby preventing the assembly of the Type III Secretion System (T3SS) and subsequent host cell invasion.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcriptional regulator HilA (HilA).